2023 annual financial data
Lakewood-Amedex Biotherapeutics 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -8,636,719 USD and net income was -8,281,960 USD.
Operating cash flow was -6,816,114 USD.
Get free Lakewood-Amedex Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -8,636,719 USD
- Net income
- -8,281,960 USD
- Operating cash flow
- -6,816,114 USD